Company intelligence / Profile preview

Sarns

Ann Arbor, Michigan, USA

Ownership: Private
Development stage: Other

Overview

Sarns was a pioneering medical technology company specializing in the design and manufacture of heart-lung machines and related perfusion equipment. Founded in 1960 by Richard Sarns, the company played a critical role in the development of modern cardiac surgery by providing reliable extracorporeal circulation systems. Its flagship products, such as the Sarns 8000 and 9000 perfusion systems, became staples in operating rooms worldwide. The company was acquired by 3M in 1981 and later sold to Terumo Corporation in 1999, where its technology continues to influence the Terumo Cardiovascular product line.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Sarns.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarns.

Explore the full profile